Mostrar el registro sencillo del ítem
| Autor | Guevara, Ana | |
| Autor | Cabello, Robinson | |
| Autor | Woelber, Linn | |
| Autor | Moreira Junior, Edson Duarte | |
| Autor | Joura, Elmar | |
| Autor | Reich, Olaf | |
| Autor | Shields, Christine | |
| Autor | Ellison, Misoo C | |
| Autor | Joshi, Amita | |
| Autor | Luxembourg, Alain | |
| Fecha de acceso | 2018-04-23T16:39:30Z | |
| Fecha de disponibilización | 2018-04-23T16:39:30Z | |
| Fecha de publicación | 2017 | |
| Referencia | GUEVARA, A. et al. Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine. Vaccine, v. 35, p. 5050–5057, 2017. | pt_BR |
| ISSN | 0264-410X | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/26034 | |
| Promoción | Merck & Co., Inc., Kenilworth, NJ, USA. | pt_BR |
| Idioma | eng | pt_BR |
| Editor | Elsevier | pt_BR |
| Derechos de autor | open access | pt_BR |
| Palabras clave en Portugués | Papiloma virus humano | pt_BR |
| Palabras clave en Portugués | Vacinas contra HPV | pt_BR |
| Palabras clave en Portugués | Imunogenicidade | pt_BR |
| Palabras clave en Portugués | Ensaio clínico | pt_BR |
| Título | Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine | pt_BR |
| Tipo del documento | Article | pt_BR |
| DOI | 10.1016/j.vaccine.2017.07.017 | |
| Resumen en Inglés | The 9-valent HPV (9vHPV) vaccine was developed to prevent infection and disease related to 9 HPV types (HPV6/11/16/18/31/33/45/52/58) which cause approximately 90% of cervical cancers, HPV-related vulvar, vaginal and anal cancers, and genital warts worldwide. In a pivotal efficacy study, the 9vHPV vaccine prevented infection and disease due to the 9 vaccine types. Duration of protection remains to be determined. Vaccines that induce long-term protection are generally characterized by the generation of immune memory. The purpose of this report is to assess the persistence of HPV antibody response and existence of immune memory at 5years post-vaccination. | pt_BR |
| Afiliación | Pablo Tobon Uribe Hospital. Research Unit. Medellin, Antioquia, Colombia | pt_BR |
| Afiliación | Vía Libre CRS. Lima, Peru | pt_BR |
| Afiliación | University Medical Center Hamburg-Eppendorf. Hamburg, Germany | pt_BR |
| Afiliación | Associação Obras Sociais Irma Dulce. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil | pt_BR |
| Afiliación | Medical University of Vienna. Comprehensive Cancer Center. Vienna, Austria | pt_BR |
| Afiliación | Medical University of Graz. Department of Obstetrics & Gynecology. Graz, Austria | pt_BR |
| Afiliación | Merck & Co. Kenilworth, NJ, USA | pt_BR |
| Afiliación | Merck & Co. Kenilworth, NJ, USA | pt_BR |
| Afiliación | Merck & Co. Kenilworth, NJ, USA | pt_BR |
| Afiliación | Merck & Co. Kenilworth, NJ, USA | pt_BR |
| Palavras clave en Inglês | Human papillomavirus | pt_BR |
| Palavras clave en Inglês | 9vHPV vaccine | pt_BR |
| Palavras clave en Inglês | Immunogenicity | pt_BR |
| Palavras clave en Inglês | Clinical trial | pt_BR |
| xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar |
Ficheros en el ítem
